Primena Taxus stentova u lečenju višesudovne koronarne bolesti srca, poređenje sa bajpas operacijom

Vladimir S Ignjatovic

doi:10.5937/mckg47-2454

Vladimir S Ignjatovic KLinicki centar Kragujevac, Klinika za kardiologiju

DOI: https://doi.org/10.5937/mckg47-2454

Sažetak

Uvod: Dugoročan ishod primene Taxus stentova u lečenju višesudovne koronarne bolesti srca je nepoznat. Ranije studije sa običnim stentovima su pokazale njihovu efikasnost uz značajno viši nivo reintervencija u odnosu na aortokoronarnu bajpas operaciju.

Cilj: Upoređivanje efikasnosti perkutane koronarne intervencije sa ugradnjom Taxus stentova i bajpas operacije kod pacijenata sa višesudovnom koronarnom bolešču, u periodu prve godine od intrvencije.

Pacijenti i metode: Radom je obuhvaćeno 114 pacijenata kojima su ugrađeni stentovi i 93 pacijenta kojima je urađena bajpas operacija tokom 2004. i 2005. godine. Efikasnost procedura iskazana je brojem ukupnih kardijalnih i cerebrovaskularnih komplikacija (smrtnost, reinfarkt, CVI, reintervencija).

Rezultati: Godinu dana nakon procedura, zbirna učestalost u grupi sa stentovima iznosila je 17.5%, od čega je samo učestalost reintervencija 11.5%. U bajpas grupi zbirna učestalost komplikacija je iznosila 14%, od čega su reintervencije činile 4.3%. Nije bilo statistički značajne razlike između učestalosti komplikacija (p=0.486) niti između učestalosti reintervencjija imeđu poređenih grupa (p=0.064).

Zaključak: Primena TAXUS stentova u lečenju višesudovne koronarne bolesti podjednako je efikasna kao i bajpas operacija posmatrano godinu dana nakon intervencije.

Ključne reči: višesudovna koronarna bolest, perkutana koronarna intervencija, bajpas operacija, TAXUS stent.

Reference

Henderson RA, Pocock SJ, Sharp SJ.Long-term results of RITA-1 trial: clinical and cost comparisons of coronary angioplasty and coronary-artery bypass grafting. Randomised Intervention Treatment of Angina. Lancet. 1998;352:1419-25.

Comparison of coronary bypass surgery with angioplasty in patients with multivessel disease. The Bypass Angioplasty Revascularization Investigation (BARI) Investigators. N Engl J Med. 1996;335:217-25.

King SB, Kosinski AS, Guyton RA, Lembo NJ, Weintraub WS.Eight-year mortality in the Emory Angioplasty versus Surgery Trial (EAST). J Am Coll Cardiol. 2000;35:1116-21.

A randomized trial comparing coronary angioplasty with coronary bypass surgery. Emory Angioplasty versus Surgery Trial (EAST). N Engl J Med. 1994;331:1044-50.

Rodriguez A, Mele E, Peyregne E, et al. Three-year follow-up of the Argentine Randomized Trial of Percutaneous Transluminal Coronary Angioplasty Versus Coronary Artery Bypass Surgery in Multivessel Disease (ERACI). J Am Coll Cardiol. 1996;27:1178-84.

Kurbaan AS, Rickards AF, Ilsley CD, et al. Relation between coronary artery disease, baseline clinical variables, revascularization mode, and mortality. CABRI Participants. Coronary Angioplasty vs. Bypass Revascularisation Investigation. Am J Cardiol. 2000;86:938-42.

Hamm CW, Reimers J, Ischinger T, Rupprecht HJ, Berger J, Bleifeld W. A randomized study of coronary angioplasty compared with bypass surgery in patients with symptomatic multivessel coronary disease. German Angioplasty Bypass Surgery Investigation (GABI). N Engl J Med. 1994;331:1037-43.

Serruys PW, Ong AT, van Herwerden LA, et al. Five-year outcomes after coronary stenting versus bypass surgery for the treatment of multivessel disease: the final analysis of the Arterial Revascularization Therapies Study (ARTS) randomized trial. J Am Coll Cardiol. 2005 16;46(4):575-81.

Hueb W, Lopes NH, Gersh BJ, et al. Five-year follow-up of the Medicine, Angioplasty, or Surgery Study (MASS II): a randomized controlled clinical trial of 3 therapeutic strategies for multivessel coronary artery disease. Circulation. 2007;115:1082-9.

Rodriguez AE, Baldi J, Fernández Pereira C, et al. Five-year follow-up of the Argentine randomized trial of coronary angioplasty with stenting versus coronary bypass surgery in patients with multiple vessel disease (ERACI II). J Am Coll Cardiol. 2005;46:582-8.

Hoffmann R, Mintz GS, Dussaillant GR, et al. Patterns and mechanisms of in-stent restenosis: a serial intravascular ultrasound study. Circulation 1996;94:1247-54.

Patric W. Serrys, Andrew T.L. Ong, Marie –Claude Morice, et al. Arterial Revascularisation Therapies Study Part II – Sirolimus-eluting stents for the thretment of patients with multivessel de novo coronary artery lesions. Euroinerv. 2005;2:147-156.

Mohr F, Serruys P, Hamm C, Robert Jm. The SYNergy between Percutaneous Coronary Intervention and Cardiac Surgery (SYNTAX) Study. ESC Congres 2008. Session number 1690-1691-1692-1693.

Varani E, Balducelli M, Vecchi G, Aquilina M, Maresta A. Comparison of multiple drug-eluting stent percutaneous coronary intervention and surgical revascularization in patients with multivessel coronary artery disease: one-year clinical results and total treatment costs. J Invasive Cardiol. 2007;19:469-75.